Priority owner: Ayman Fanous, MD

Priority vision: Pursue distinction in prioritized areas of greatest clinical and scientific impact to our community.

Goals and Initiatives

DD1. Make strategic investments in high-impact research programs, focusing on advanced technologies, AI and large-scale multi-omic datasets.

  • DD1a. Establish competitive pilot/seed funding opportunities for researchers.
  • DD1b. Emphasize strength in neuroscience, cardiopulmonary, immunological therapy and health across lifespan.

DD2. Leverage access to clinical affiliates' large diverse patient populations to accelerate discovery and improve quality of care.

  • DD2a. Establish tech-enabled, streamlined access to clinical affiliate data. 
  • DD2b. Build upon and foster clinical learner successes in identifying research opportunities that result in notable presentations and publications.

DD3. Create economic opportunities by translating discoveries into new and improved prevention and treatment modalities.

  • DD3a. Coordinate with the Phoenix Biomedical Core (PBC) to target industry partners to further intellectual property (IP) development and advanced care opportunities.
Key Accomplishments